Paul Rutherford Carter Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul Rutherford Carter.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul Rutherford Carter. Paul Rutherford Carter is EVP Commercial Ops in GILEAD SCIENCES INC ($GILD) and Director in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Director in Mallinckrodt plc ($MNK).
Latest Insider Trading Transactions of Paul Rutherford Carter
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALDR, GILD, MNK
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Carter Paul Rutherford | Director | Option Exercise | D | 11.01 | 22,500 | 247,725 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Carter Paul Rutherford | Director | Option Exercise | D | 15.50 | 15,000 | 232,500 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Carter Paul Rutherford | Director | Option Exercise | D | 16.90 | 15,000 | 253,500 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Carter Paul Rutherford | Director | Option Exercise | D | 29.26 | 15,000 | 438,900 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Carter Paul Rutherford | Director | Option Exercise | D | 31.10 | 30,000 | 933,000 | 0 | |
| May 28 2019 | ALDR | ALDER BIOPHARMACEU ... | Carter Paul Rutherford | Director | Option Exercise | A | 11.01 | 22,500 | 247,725 | 22,500 | |
| May 17 2019 | MNK | Mallinckrodt plc | Carter Paul Rutherford | Director | Grant | A | 0.00 | 19,396 | 0 | 29,437 | 10 K to 29.4 K (+193.17 %) |
| May 17 2019 | MNK | Mallinckrodt plc | Carter Paul Rutherford | Director | Payment of Exercise | F | 15.21 | 8,906 | 135,460 | 10,041 | 18.9 K to 10 K (-47.00 %) |
| May 25 2018 | ALDR | ALDER BIOPHARMACEU ... | Carter Paul Rutherford | Director | Option Exercise | A | 15.50 | 15,000 | 232,500 | 15,000 | |
| May 18 2018 | MNK | Mallinckrodt plc | Carter Paul Rutherford | Director | Grant | A | 0.00 | 18,947 | 0 | 18,947 | 0 to 18.9 K |
| May 26 2017 | ALDR | ALDER BIOPHARMACEU ... | Carter Paul Rutherford | Director | Option Exercise | A | 16.90 | 15,000 | 253,500 | 15,000 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 183 | 4,558 | 26,043 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 183 | 4,558 | 26,043 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 183 | 4,558 | 26,043 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 1,817 | 73,698 | 4,803 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 1,817 | 73,698 | 4,803 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 1,817 | 73,698 | 4,803 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 79.81 | 2,000 | 159,620 | 62,305 | 64.3 K to 62.3 K (-3.11 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 79.81 | 2,000 | 159,620 | 62,305 | 64.3 K to 62.3 K (-3.11 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 79.81 | 2,000 | 159,620 | 62,305 | 64.3 K to 62.3 K (-3.11 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 183 | 4,558 | 64,305 | 64.1 K to 64.3 K (+0.29 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 183 | 4,558 | 64,305 | 64.1 K to 64.3 K (+0.29 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 183 | 4,558 | 64,305 | 64.1 K to 64.3 K (+0.29 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 1,817 | 73,698 | 64,122 | 62.3 K to 64.1 K (+2.92 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 1,817 | 73,698 | 64,122 | 62.3 K to 64.1 K (+2.92 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 1,817 | 73,698 | 64,122 | 62.3 K to 64.1 K (+2.92 %) |
| Aug 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 0.00 | 2,500 | 0 | 2,500 | |
| Aug 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Payment of Exercise | F | 79.47 | 1,317 | 104,662 | 62,305 | 63.6 K to 62.3 K (-2.07 %) |
| Aug 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 0.00 | 2,500 | 0 | 63,622 | 61.1 K to 63.6 K (+4.09 %) |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 2,000 | 49,810 | 26,226 | |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 83.12 | 2,000 | 166,250 | 61,122 | 63.1 K to 61.1 K (-3.17 %) |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 2,000 | 49,810 | 63,122 | 61.1 K to 63.1 K (+3.27 %) |
| Jun 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 2,000 | 49,810 | 28,226 | |
| Jun 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 87.02 | 2,000 | 174,040 | 61,122 | 63.1 K to 61.1 K (-3.17 %) |
| Jun 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 2,000 | 49,810 | 63,122 | 61.1 K to 63.1 K (+3.27 %) |
| Jun 02 2016 | ALDR | ALDER BIOPHARMACEU ... | Carter Paul Rutherford | Director | Option Exercise | A | 29.26 | 15,000 | 438,900 | 15,000 | |
| Jun 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 80.65 | 3,865 | 311,712 | 16,906 | |
| Jun 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 80.65 | 5,795 | 467,367 | 0 | |
| Jun 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 4,232 | 105,398 | 30,226 | |
| Jun 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.30 | 43,200 | 1,049,544 | 0 | |
| Jun 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 86.85 | 57,092 | 4,958,600 | 61,122 | 118.2 K to 61.1 K (-48.30 %) |
| Jun 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 80.65 | 3,865 | 311,712 | 118,214 | 114.3 K to 118.2 K (+3.38 %) |
| Jun 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 80.65 | 5,795 | 467,367 | 114,349 | 108.6 K to 114.3 K (+5.34 %) |
| Jun 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 4,232 | 105,398 | 108,554 | 104.3 K to 108.6 K (+4.06 %) |
| Jun 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.30 | 43,200 | 1,049,544 | 104,322 | 61.1 K to 104.3 K (+70.68 %) |
| May 04 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 183 | 4,558 | 34,458 | |
| May 04 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 1,817 | 73,698 | 6,620 | |
| May 04 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 88.72 | 2,000 | 177,448 | 61,122 | 63.1 K to 61.1 K (-3.17 %) |
| May 04 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 183 | 4,558 | 63,122 | 62.9 K to 63.1 K (+0.29 %) |
| May 04 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 1,817 | 73,698 | 62,939 | 61.1 K to 62.9 K (+2.97 %) |
| Apr 05 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 2,000 | 49,810 | 34,641 | |
| Apr 05 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 91.34 | 2,000 | 182,680 | 61,122 | 63.1 K to 61.1 K (-3.17 %) |
| Apr 05 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 2,000 | 49,810 | 63,122 | 61.1 K to 63.1 K (+3.27 %) |
| Mar 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 2,000 | 49,810 | 36,641 | |
| Mar 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 87.90 | 2,000 | 175,800 | 61,122 | 63.1 K to 61.1 K (-3.17 %) |
| Mar 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 2,000 | 49,810 | 63,122 | 61.1 K to 63.1 K (+3.27 %) |
| Feb 18 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Payment of Exercise | F | 91.15 | 7,395 | 674,054 | 61,122 | 68.5 K to 61.1 K (-10.79 %) |
| Feb 18 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Grant | A | 0.00 | 9,554 | 0 | 68,517 | 59 K to 68.5 K (+16.20 %) |
| Feb 18 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Grant | A | 0.00 | 9,932 | 0 | 58,963 | 49 K to 59 K (+20.26 %) |
| Feb 18 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Grant | A | 76.02 | 248 | 18,854 | 49,031 | 48.8 K to 49 K (+0.51 %) |
| Feb 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | A | 84.05 | 42,880 | 3,604,064 | 42,880 | |
| Feb 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 1,818 | 73,738 | 8,437 | |
| Feb 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 182 | 4,533 | 38,641 | |
| Feb 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 82.32 | 2,000 | 164,640 | 48,783 | 50.8 K to 48.8 K (-3.94 %) |
| Feb 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 1,818 | 73,738 | 50,783 | 49 K to 50.8 K (+3.71 %) |
| Feb 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 182 | 4,533 | 48,965 | 48.8 K to 49 K (+0.37 %) |
| Jan 06 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 823 | 22,213 | 0 | |
| Jan 06 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 1,177 | 29,313 | 38,823 | |
| Jan 06 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 99.20 | 2,000 | 198,400 | 48,783 | 50.8 K to 48.8 K (-3.94 %) |
| Jan 06 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 1,177 | 29,313 | 50,783 | 49.6 K to 50.8 K (+2.37 %) |
| Jan 06 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 26.99 | 823 | 22,213 | 49,606 | 48.8 K to 49.6 K (+1.69 %) |
| Dec 03 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 2,000 | 53,980 | 823 | |
| Dec 03 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 106.38 | 2,000 | 212,760 | 48,783 | 50.8 K to 48.8 K (-3.94 %) |
| Dec 03 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 26.99 | 2,000 | 53,980 | 50,783 | 48.8 K to 50.8 K (+4.10 %) |
| Nov 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 1,816 | 73,657 | 10,255 | |
| Nov 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 184 | 4,966 | 2,823 | |
| Nov 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 108.36 | 2,000 | 216,712 | 48,783 | 50.8 K to 48.8 K (-3.94 %) |
| Nov 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | M | 40.56 | 1,816 | 73,657 | 50,783 | 52.6 K to 50.8 K (-3.45 %) |
| Nov 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | M | 26.99 | 184 | 4,966 | 48,967 | 49.2 K to 49 K (-0.37 %) |
| Oct 28 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 1,500 | 40,485 | 3,007 | |
| Oct 28 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 110.06 | 1,500 | 165,092 | 48,783 | 50.3 K to 48.8 K (-2.98 %) |
| Oct 28 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | M | 26.99 | 1,500 | 40,485 | 50,283 | 51.8 K to 50.3 K (-2.90 %) |
| Oct 05 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 1,820 | 73,819 | 12,071 | |
| Oct 05 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 180 | 4,858 | 4,507 | |
| Oct 05 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 98.59 | 2,000 | 197,180 | 48,783 | 50.8 K to 48.8 K (-3.94 %) |
| Oct 05 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | M | 40.56 | 1,820 | 73,819 | 50,783 | 52.6 K to 50.8 K (-3.46 %) |
| Oct 05 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | M | 26.99 | 180 | 4,858 | 48,963 | 49.1 K to 49 K (-0.37 %) |
| Sep 30 2015 | ALDR | ALDER BIOPHARMACEU ... | Carter Paul Rutherford | Director | Option Exercise | A | 31.10 | 30,000 | 933,000 | 30,000 | |
| Aug 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 5,000 | 134,950 | 4,687 | |
| Aug 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 120.00 | 2,000 | 240,000 | 48,783 | 50.8 K to 48.8 K (-3.94 %) |
| Aug 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 118.64 | 3,000 | 355,920 | 50,783 | 53.8 K to 50.8 K (-5.58 %) |
| Aug 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 26.99 | 5,000 | 134,950 | 53,783 | 48.8 K to 53.8 K (+10.25 %) |
| Aug 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 0.00 | 2,500 | 0 | 5,000 | |
| Aug 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Payment of Exercise | F | 117.86 | 1,349 | 158,993 | 48,783 | 50.1 K to 48.8 K (-2.69 %) |
| Aug 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 0.00 | 2,500 | 0 | 50,132 | 47.6 K to 50.1 K (+5.25 %) |
| Jul 06 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 3,000 | 80,970 | 9,687 | |
| Jul 06 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 118.24 | 3,000 | 354,729 | 47,632 | 50.6 K to 47.6 K (-5.93 %) |
| Jul 06 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 26.99 | 3,000 | 80,970 | 50,632 | 47.6 K to 50.6 K (+6.30 %) |
| Jun 22 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 10,000 | 269,900 | 12,687 | |
| Jun 22 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 120.00 | 10,000 | 1,200,025 | 47,632 | 57.6 K to 47.6 K (-17.35 %) |
| Jun 22 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 26.99 | 10,000 | 269,900 | 57,632 | 47.6 K to 57.6 K (+20.99 %) |
| Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 1,706 | 69,195 | 13,891 | |
| Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 1,294 | 34,925 | 22,687 | |
| Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 113.09 | 3,000 | 339,278 | 47,632 | 50.6 K to 47.6 K (-5.93 %) |
| Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 26.99 | 1,294 | 34,925 | 50,632 | 49.3 K to 50.6 K (+2.62 %) |
| Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 1,706 | 69,195 | 49,338 | 47.6 K to 49.3 K (+3.58 %) |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 80.65 | 4,074 | 328,568 | 26,566 | |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 1,926 | 78,119 | 15,597 | |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 110.00 | 6,000 | 660,020 | 47,632 | 53.6 K to 47.6 K (-11.19 %) |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 1,926 | 78,119 | 53,632 | 51.7 K to 53.6 K (+3.72 %) |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 80.65 | 4,074 | 328,568 | 51,706 | 47.6 K to 51.7 K (+8.55 %) |
| May 12 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 0.00 | 5,000 | 0 | 7,500 | |
| May 12 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Payment of Exercise | F | 103.85 | 2,807 | 291,507 | 47,632 | 50.4 K to 47.6 K (-5.57 %) |
| May 12 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 0.00 | 5,000 | 0 | 50,439 | 45.4 K to 50.4 K (+11.00 %) |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 80.65 | 2,000 | 161,300 | 30,640 | |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 103.18 | 2,000 | 206,365 | 45,439 | 47.4 K to 45.4 K (-4.22 %) |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 80.65 | 2,000 | 161,300 | 47,439 | 45.4 K to 47.4 K (+4.40 %) |
| Apr 09 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 80.65 | 205 | 16,533 | 32,640 | |
| Apr 09 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 80.65 | 795 | 64,117 | 32,845 | |
| Apr 09 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 100.00 | 1,000 | 100,000 | 45,439 | 46.4 K to 45.4 K (-2.15 %) |
| Apr 09 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 80.65 | 205 | 16,533 | 46,439 | 46.2 K to 46.4 K (+0.44 %) |
| Apr 09 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 80.65 | 795 | 64,117 | 46,234 | 45.4 K to 46.2 K (+1.75 %) |
| Apr 03 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 80.65 | 1,000 | 80,650 | 33,640 | |
| Apr 03 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 98.04 | 1,000 | 98,044 | 45,439 | 46.4 K to 45.4 K (-2.15 %) |
| Apr 03 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 80.65 | 1,000 | 80,650 | 46,439 | 45.4 K to 46.4 K (+2.20 %) |
| Mar 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 80.65 | 2,000 | 161,300 | 34,640 | |
| Mar 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 104.18 | 2,000 | 208,364 | 45,439 | 47.4 K to 45.4 K (-4.22 %) |
| Mar 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 80.65 | 2,000 | 161,300 | 47,439 | 45.4 K to 47.4 K (+4.40 %) |
| May 13 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 0.00 | 5,000 | 0 | 19,800 | |
| May 13 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Payment of Exercise | F | 79.76 | 2,857 | 227,874 | 18,433 | 21.3 K to 18.4 K (-13.42 %) |
| May 13 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 0.00 | 5,000 | 0 | 21,290 | 16.3 K to 21.3 K (+30.69 %) |
| May 12 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 16,728 | 451,489 | 74,448 | |
| May 12 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 78.80 | 16,728 | 1,318,143 | 28,562 | 45.3 K to 28.6 K (-36.94 %) |
| May 12 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 26.99 | 16,728 | 451,489 | 45,290 | 28.6 K to 45.3 K (+58.57 %) |
| Apr 10 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 8,824 | 238,160 | 91,176 | |
| Apr 10 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 21.58 | 7,904 | 170,529 | 0 | |
| Apr 10 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 70.20 | 6,328 | 444,205 | 28,562 | 34.9 K to 28.6 K (-18.14 %) |
| Apr 10 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 70.73 | 10,400 | 735,577 | 34,890 | 45.3 K to 34.9 K (-22.96 %) |
| Apr 10 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 26.99 | 8,824 | 238,160 | 45,290 | 36.5 K to 45.3 K (+24.20 %) |
| Apr 10 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 21.58 | 7,904 | 170,529 | 36,466 | 28.6 K to 36.5 K (+27.67 %) |
| Mar 12 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 21.58 | 16,728 | 360,907 | 7,904 | |
| Mar 12 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 79.32 | 16,728 | 1,326,833 | 28,562 | 45.3 K to 28.6 K (-36.94 %) |
| Mar 12 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 21.58 | 16,728 | 360,907 | 45,290 | 28.6 K to 45.3 K (+58.57 %) |
| Mar 10 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Payment of Exercise | F | 79.92 | 11,280 | 901,498 | 28,562 | 39.8 K to 28.6 K (-28.31 %) |
| Mar 10 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Grant | A | 0.00 | 24,000 | 0 | 39,842 | 15.8 K to 39.8 K (+151.50 %) |
| Mar 04 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 30,000 | 747,150 | 40,000 | |
| Mar 04 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 23.60 | 69,000 | 1,628,400 | 0 | |
| Mar 04 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 83.55 | 99,000 | 8,271,935 | 15,842 | 114.8 K to 15.8 K (-86.21 %) |
| Mar 04 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 30,000 | 747,150 | 114,842 | 84.8 K to 114.8 K (+35.36 %) |
| Mar 04 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 23.60 | 69,000 | 1,628,400 | 84,842 | 15.8 K to 84.8 K (+435.55 %) |